GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Upstream Bio Inc (NAS:UPB) » Definitions » Price-to-Funds-From-Operations

UPB (Upstream Bio) Price-to-Funds-From-Operations : (As of Apr. 08, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Upstream Bio Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Upstream Bio Business Description

Industry
Traded in Other Exchanges
N/A
Address
890 Winter Street, Suite 200, Waltham, MA, USA, 02451
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.